CTRI/2021/09/036375
Recruiting
未知
A Prospective, Multicentric, Registry to Evaluate the Impact of FFR and OCT on the Outcomes of PCI in Diabetic Patients - iFOCUS - iFOCUS Registry
Ananthapuri Hospitals and Research Institute0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ananthapuri Hospitals and Research Institute
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Diabetes inclusion criteria
- •a. Previously diagnosed and currently on diabetes medication
- •b. Patient having any one of the below as per American Diabetes Association criteria (HbA1c ââ?°Â¥6\.5% or Fasting plasma glucose ââ?°Â¥126 mg/dL (7\.0 mmol/L) or 2\-hour glucose ââ?°Â¥200 mg/dL (11\.1mmol/L))
- •2\. Patients of either gender, aged ââ?°Â¥ 18 years
- •3\. DM patients with single or multivessel lesions in native vessels, undergoing PCI and suitable for invasive cardiovascular diagnostic procedures, FFR and OCT
- •4\. Patients with Unstable Angina, stable ischemic heart disease, or NSTEMI
- •5\. Willing to provide inform consent to share the data
Exclusion Criteria
- •1\. Patients unwilling to sign the informed consent
- •2\. Hemodynamic instability or cardiogenic shock patients
- •3\. Patients who have a life expectancy of less than 12 months
- •4\. Contraindication for dual antiplatelet therapy (DAPT)
- •5\. Patients with Chronic Total Occlusion lesions, Aorto\-Ostial lesions
- •6\. Prior CABG patients
- •7\. Lesions with in\-stent restenosis
- •8\. Left Main disease patients
- •9\. Patients with GFR \< 30 ml/min
- •10\. Patients with KILLIP class III or IV
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A follow up study to evaluate the safety and effectiveness of tissue valve (aortic) among Indian patientsHealth Condition 1: I358- Other nonrheumatic aortic valve disordersCTRI/2022/08/044557SRM Institutes for Medical Science SIMS
Active, not recruiting
Not Applicable
An observational registry study on the use of ENCRUSO RAL- Everolimus eluting stent in indian populatioCTRI/2022/03/040921ano Therapeutics Private Limited
Recruiting
Phase 4
Prospective, Single center, Registry to Evaluate the Long-term Clinical Safety and Efficacy of the Resolute Integrity drug eluting stent in an all-comers population.Coronary artery disease (CAD)JPRN-UMIN000009909Department of Cardiovascular Internal Medicine, Kuki General Hospital1,000
Recruiting
Phase 4
A Observational Study to Evaluate Sirolimus Eluting Coronary Stent for the Treatment of the narrowing of the coronary artery, resulting in a poor blood flow to your heart muscle.CTRI/2012/04/002612Multimedics400
Withdrawn
Not Applicable
A Multi-Center InternatiONal Registry to Evaluate the Efficacy oF Imaging with Opto-acoustics to Diagnose BrEast CaNCErNL-OMON46537Seno Medical Instruments, Inc.150